Serum soluble interleukin-2 receptor in eosinophilia

Acta Haematologica

Volumn 109, Issue 1, 2003, Pages 23-28

  Kaito, Ken ^a,b   Otsubo, Hiroko ^b   Ogasawara, Yoji ^b   Kimura, Hiroko ^a   Kurihara, Etsuko ^a   Koike, Masaru ^a   Aiso, Masayoshi ^a   Kobayashi, Masayuki ^b  

^a JIKEI UNIVERSITY HOSPITAL   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Eosinophilia; IgE; Interleukin 2 receptor, soluble

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; BIOLOGICAL MARKER;

ADULT; AGED; ALLERGY; ARTICLE; COLLAGEN DISEASE; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; ADOLESCENT; BLOOD; HOSPITALIZATION; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PATHOLOGY; SOLUBILITY; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DATA INTERPRETATION, STATISTICAL; EOSINOPHILIA; EOSINOPHILS; FEMALE; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; SEVERITY OF ILLNESS INDEX; SOLUBILITY;

EID: 0037208859     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067274     Document Type: Article

References (12)

1. Chilosi M, Semenzato G, Vinante F, Menetrina F, Piazzola E, Focchiatti V, Sabbioni R, Zanotti R, Pizzolo G: Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphoma: Relationship with clinical, histologic, and phenotypic features. Am J Clin Pathol 1989;92:186-191.
2. Stasi R, Zinzani PL, Galieni P, Lauta VM, Damasio E, Dispensa E, Dammacco F, Paga G, Tura S: Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphoma. Br J Haematol 1994;88: 770-777.
3. Zerler B: The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells 1991;3:471-479.
4. Sanderson CJ, O'Garra A, Warren DJ, Klaus GG: Eosinophil differentiation factor also has B-cell growth factor activity: Proposed name interleukin-4. Proc Natl Acad Sci USA 1986; 83:437-440.
5. Campbell HD, Tucker WQ, Hort Y, Martinson ME, Mayo G, Vlutterbuck EJ, Sanderson CJ, Young IG: Molecular cloning, nucleotide sequence, and expression of the gene encoding human eosinophil differentiation factor (interleukin-5). Proc Natl Acad Sci USA 1987;84: 6629-6633.
6. Sonoda Y, Arai N, Ogawa M: Humoral regulation of eosinophilopoiesis in vitro: Analysis of the targets of interleukin-3, granulocyte/macrophage colony stimulating factor (GM-CSF), and interleukin-5. Leukemia 1989;3:14-18.
7. Roufosse F, Schandene L, Sibille C, Willard-Gallo K, Kennes B, Efira A, Goldman M, Cogan E: Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol 2000;109:540-548.
8. Prin L, Plumas J, Gruart V, Loiseau S, Aldebert D, Ameisen JC, Vermersch A, Fenaux P, Bletry O, Capron M: Elevated serum levels of soluble interleukin-2 receptor: A marker of disease activity in the hypereosinophilic syndrome. Blood 1991;78:2626-2632.
9. Furue M, Sugiyama H, Tsukamoto K, Ohtake N, Tamaki K: Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis. J Dermatol Sci 1994;7:89-95.
10. Putterman C, Barak V, Caraco Y, Neuman T, Shalit M: Episodic angioedema with eosinophilia: A case associated with T cell activation and cytokine production. Ann Allergy 1993;70: 243-248.
11. McKinley KL, Harati Y, Schneider LW: Chronic immune activation in the eosinophilia-myalgia syndrome. Muscle Nerve 1993; 16:1228-1229.
12. Lassalle P, Sergant M, Delneste Y, Gosset P, Wallaert B, Zandecki M, Capron A, Joseph M, Tonnel AB: Levels of soluble IL-2 receptor in plasma from asthmatics. Correlations with blood eosinophilia, lung function, and corticosteroid therapy. Clin Exp Immunol 1992;87: 266-271.